Safety of drugs used for the treatment of Crohn’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of drugs used for the treatment of Crohn’s disease

Published:2019-05-04 Issue:5 Volume:18 Page:357-367
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Pudipeddi Aviv¹²,Kariyawasam Viraj¹²^ORCID,Haifer Craig¹²,Baraty Brandon¹²,Paramsothy Sudarshan¹²³,Leong Rupert WL¹²³⁴^ORCID

Affiliation:

1. Department of Gastroenterology and Liver Services, Concord Hospital, Sydney, Australia

2. Faculty of Medicine and Health, University of Sydney, Sydney, Australia

3. Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia

4. Faculty of Medicine, UNSW, Sydney, Australia

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1612874

Reference98 articles.

1. Optimizing the use of biological therapy in patients with inflammatory bowel disease

2. Early Use of Thiopurines or Methotrexate Reduces Major Abdominal and Perianal Surgery in Crohnʼs Disease

3. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

4. Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peiminine ameliorates Crohn’s disease-like colitis by enhancing the function of the intestinal epithelial barrier through Nrf2/HO1 signal;International Immunopharmacology;2024-07

2. Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort;Gastroenterología y Hepatología;2024-05

3. The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study;Therapeutic Advances in Gastroenterology;2024-01

4. Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy;Saudi Journal of Gastroenterology;2023-12-15

5. Crohn’s disease and intestinal tuberculosis: challenging from every angle;BMJ Case Reports;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3